![]() The global Gastroesophageal Reflux Disease (GERD) Therapeutics Market is expected to reach USD 4.34 billion by 2025, according to a new study by Grand View Research, Inc. The incidence of acid reflux disorder, also known as heartburn, is rapidly increasing worldwide. Various studies state that almost every person experiences acid reflux once in a lifetime. The overall market has been experiencing a downturn in terms of revenue in the past several years as the leading drugs for GERD treatment have lost their patent protection, with their market shares now largely consumed by over-the-counter (OTC) and generic medications. Although loss of exclusivity of high-grossing drugs have caused a market fall-off, the demand for acid reducing drugs due to the high prevalence and incidence levels of GERD will prove beneficial to the industry from a commercial standpoint. GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide. The prevalence of acid reflux and related symptoms has increased across the globe by nearly 50% over the last decade. This disorder not only has major effects on the health and quality of patient lives, but also extends to the healthcare system and economy. In addition, the occurrence of acid reflux disease increases with age, rendering elderly people more prone to developing a severe form of heartburn. The geriatric subset hence forms a prominent target population for GERD therapeutics. To request a sample copy or view summary of this report, click the link below: http://www.grandviewresearch.com/industry-analysis/gastroesophageal-reflux-disease-gerd-therapeutics-market Further key findings from the study suggest:
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/
0 Comments
![]() The global Astaxanthin Market is expected to reach USD 2.57 billion by 2025, according to a new report by Grand View Research, Inc. Adoption of advanced technologies in various stages of natural astaxanthin production, such as microalgae harvesting, cultivation, extraction, and drying, have been major factors driving market growth. Moreover, awareness about health benefits, safety, and potential uses of astaxanthin is another driving force. Rising geriatric population is estimated to result in an increase in the demand for cosmetics such as antiageing creams and antioxidant products for improving aesthetic appeal. Astaxanthin has been reported in many studies for its high antioxidant and skin-friendly properties. Due to this, many cosmeceutical manufacturers and wellness spa owners are using it in new products and associated therapies, which is also estimated to drive demand. To request a sample copy or view summary of this report, click the link below: http://www.grandviewresearch.com/industry-analysis/global-astaxanthin-market Further Key Findings From the Report Suggest:
Astaxanthin Source Technology Outlook (Revenue, USD Million, 2014 - 2025)
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ ![]() The global Regulatory Affairs Outsourcing Market size is expected to reach USD 13.9 billion by 2026, according to a new report by Grand View Research, Inc. it is projected to register a CAGR of 11.9% during the forecast period. Outsourcing regulatory affairs activities to the Contract Research Organizations (CROs) offers cost efficiency, reduced regulatory submission time, and quality control in the overall manufacturing process. These factors are anticipated to propel the growth over the forecast period. Large companies address capacity problems and lack of expertise in their internal departments through outsourcing to smaller mid-size companies. It also eliminates additional work load and consolidates regulatory departments to avoid duplication of work. Regulatory affairs include activities such as drug master files, technical writing, and review of Chemistry, Manufacturing, and Controls (CMC), eCTD conversion, query management, Investigational New Drug (IND) maintenance, serious adverse events reporting, labeling, and drug shipment approvals for clinical trials. Regulatory affairs outsourcing witnessed few important industry events. For instance, in August 2018, U.K. based Syneos Health acquired Kinapse, a provider of pharmaco-vigilance consulting and post market regulatory services. With this acquisition, the company aims to double its consulting footprint in Europe and associated commercial services. Moreover, in October 2018, PAREXEL International Corporation introduced the new China Advisory Services to help pharmaceutical companies in seeking market opportunities within China, to have an early mover advantage. The services include agency engagements, market access, and commercial strategies. This happened on the backdrop of recent reforms implemented by the National Medicinal Products Administration (NMPA), such as expedited approvals, faster Multi-regional Clinical Trials (MCT) applications, and clinical trial approvals in two months. To request a sample copy or view summary of this report, click the link below: https://www.grandviewresearch.com/industry-analysis/regulatory-affairs-outsourcing-market Further key findings from the report suggest:
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ ![]() The global Medical Flexible Packaging Market is expected to reach USD 34.62 billion by 2025, according to a new report by Grand View Research, Inc. The growing demand for medical devices and implants coupled with innovation in packaging materials is driving the demand for these products. Flexible packaging provides many advantages as it is lightweight, has increased shelf life, and consumes less amount of material. Medical flexible packaging products are expected to experience increased demand over the forecast period owing to the presence of a wide variety of offerings that cater to specific purposes. The development of eco-friendly high strength paper is expected to further augment the market demand. North America was the largest regional market in 2016 backed by the thriving medical device and implant manufacturing industries. The presence of advanced medical device manufacturers with specialized packaging needs is expected to drive the demand for these products. The improving economic outlook and growing innovation on barrier materials are expected to have a positive impact on the consumption in North America. The presence of major companies such as Amcor and Bemis is expected to further boost the consumption over the forecast period. To request a sample copy or view summary of this report, click the link below: http://www.grandviewresearch.com/industry-analysis/medical-flexible-packaging-market Further key findings from the report suggests:
Material Outlook (Revenue, USD Billion; 2014 - 2025)
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ ![]() Global Cosmetic Dentistry Market is expected to reach USD 27.95 billion by 2024, according to a new report by Grand View Research, Inc. More and more people are opting for esthetic dental procedures, which has resulted in development of advanced technologies. Cognizance among populations about such techniques and procedures has allowed this industry to prosper by leaps and bounds. Developing countries have generated a significant amount of disposable income, which is the main reason why cosmetic dentistry is flourishing. Geriatric population, in general, has propagated the growth of this industry with old-age-related tooth ailments. Treatments that include teeth whitening, change in dental appearance, and intervention of malocclusion are the most frequent procedures that patients undergo in cosmetic dentistry. Dental tourism has been one of the most important reasons for cosmetic dentistry to prosper globally. The major restraints in this market are lack of reimbursement options for cosmetic procedures and expensive cost of dental imaging. Insurance companies and government agencies do not regard cosmetic procedures as essential and thus, not many reimbursement options are available for cosmetic dentistry. On the other hand, dental imaging requires technologically advanced equipment requiring huge investments that are not covered by insurance companies. This is another reason that hinders the growth of this sector. On the basis of the products, this industry is segmented into dental systems and equipment, dental implants, dental bridges, dental crowns, dental veneers, orthodontic braces, bonding agents, and, inlays & onlays. The major market share in case of products was accounted for by dental systems and equipment, as they include a wide range of products that are used in a majority of the dental procedures. With an escalation in individuals opting for cosmetic dentistry, dental braces are also used extensively to alter the alignment of teeth. With CAD/CAM systems, the designing of dental prosthetics has become relatively easy allowing 3D technology to be used extensively, which has drastically improved accuracy of procedures. Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/cosmetic-dentistry-market Further Key Findings from the Study Suggest:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ The global Urinary Catheters Market is expected to reach USD 5.51 billion by 2024, according to a new report by Grand View Research, Inc. The key contributors for the expansion of the market include the rising incidence of urinary disorders, growing elderly population, and technological advancements pertaining to the relevant devices.
These catheters have application in patients suffering from urinary retention, urinary incontinence, benign prostatic hyperplasia, and other disorders. Patients suffering from multiple sclerosis, spina bifida, cerebral palsy, spinal cord injuries, prostate enlargement, and cancer also require need them The WHO states that bladder problems affect more than 200 million people globally. Benign Prostate Hyperplasia (BPH) is most common in the ageing population, especially men, and urinary retention is a very common complication in BPH. Transurethral resection of the prostate is a common surgery for BPH and the Urology Care Foundation estimates that around 150,000 men in the U.S. undergo this surgery each year. The technological development pertaining to these instruments are expected to drive the demand further. The catheters become infected after a couple of weeks and can cause infection of the tract. The development of new antimicrobial catheters with introduced antimicrobial molecules within the tube has advantage over the traditional ones. Furthermore, the reimbursement policies for these products can also be attributed to the growing demand. The Medicaid program reimburses a patient with 120 intermittent catheters per month and the Medicare Program reimburses around 200 catheters per month. Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/urinary-catheters-market Further Key Findings From the Study Suggest:
Urinary Catheters Product Type Outlook (Market revenue in USD Million, 2013 - 2024)
![]() Global Allergy Diagnostics And Therapeutics Market is expected to reach USD 40.8 billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of allergic conditions and adoption of immunoassay as a viable diagnostic test is expected to serve this market with lucrative future growth opportunities. The prevalence of target diseases such as asthma and food allergies are expected to grow over the next seven years, supported by sedentary and dietary lifestyle habits. In addition, rising indoor, industrial pollution, rapid urbanization in developing countries and increasing greenhouse gas concentrations are expected to increase the prevalence of pollen induced respiratory disorder, thereby boosting the overall market growth over the forecast period. Increasing incidences of allergies has triggered the demand for sensitive, cost effective and accurate diagnostics tools. Manufacturers in congruence with the changing customer preferences are now engaged in constant product development. For instance, the MeDALL allergen-chip for allergy determination is further expected to propel market growth during the next seven years. Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/allergy-diagnostic-market Further key findings from the study suggest:
Global Allergy Diagnostics Product Outlook (Revenue, USD Million, 2012 - 2022)
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ ![]() The global Small Animal Imaging (In-Vivo) Market size is expected to reach $2.7 billion by 2022, according to a new report by Grand View Research, Inc., progressing at a CAGR of 9.0% during the forecast period. Rising number of medical conditions requiring precise research for development of treatment options is anticipated to stoke the demand for small animal imaging over the forecast period. Importance of these devices in applications such as defining mechanism of action, drug receptor targeting, and epigenetic research studies are projected to provide substantial growth for the market. Some of the major drivers of small animal imaging (in-vivo) market are technical innovations such as high-resolution MRI with other modalities, growing number of research and pharmaceutical organizations, increasing investments of CROs in pre-clinical studies, and rising adoption of multi-functional pre-clinical imaging. Access Research Report of Small Animal Imaging (In-vivo) Market @ https://www.grandviewresearch.com/industry-analysis/small-animal-imaging-in-vivo-market Further key findings from the report suggest:
Small Animal Imaging (In-vivo) Technology Outlook (Revenue, USD Million, 2012 - 2022)
About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. For More Information: www.grandviewresearch.com The global Cerebral Spinal Fluid (CSF) Management Market is anticipated to reach USD 1.4 billion by 2022, according to a new report by Grand View Research, Inc. Constant evaluation of various techniques by neurosurgeons for improvement of hydrocephalus management is expected to drive growth in this market. Moreover, shunt manufacturers are engaged in the investment for development of novel and improved shunts in order to tackle the pitfalls associated with the existing designs.
Significant increase in geriatric population across the globe as well as raise in incidence of chronic CNS associated disorders such as stroke can be attributed to projected growth. Furthermore, grants for research in neuromodulation therapies in order to develop different products for prognosis of various nervous system associated disorders are expected to boost development. Access Research Report of Physiotherapy Equipment Market @ http://www.grandviewresearch.com/industry-analysis/csf-management-market-analysis-market Further Key Findings from the Study Suggest:
CSF Management Product Outlook (Revenue, USD Million, 2012 - 2022)
Browse more reports of this category by Grand View Research @ https://www.grandviewresearch.com/industry/medical-devices About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. For More Information: www.grandviewresearch.com |
Archives
October 2023
|